BioNTech SE - ADR

NASDAQ:BNTX  
278.22
-8.14 (-2.84%)
Products, Expansion

Pfizer Goes It Alone To Expand Vaccine Business Beyond COVID-19 Pandemic - WSJ

Published: 03/23/2021 09:45 GMT
BioNTech SE - ADR (BNTX) - Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic - Wsj.
Pfizer Will Develop New Shots Using Technology, Called Mrna, to Target Other Viruses and Pathogens Beyond the Coronavirus - Wsj.
Pfizer and Biontech Will Continue to Collaborate on Covid-19 Shots- Wsj.
Pfizer CEO Says "we Like Working With Biontech, But We Don't Need to Work With Biontech" - Wsj.
Pfizer Would Start Manufacturing Some Experimental Products Before They Prove to Work Safely, As It Did With Covid-19 Vaccine - Wsj.
Pfizer Will Increase Research and Development in Mrna Technology, Including Adding at Least 50 Employees Whose Assignments Will Include Mrna - Wsj.